SCHEMBL12433947

SCHEMBL12433947

c1ccc(N(c2ccccc2)c2ccc(-c3cc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)c4ccc5cccc6ccc3c4c65)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.40
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40
ALDH1A1 P00352 9/20 0.36
L3MBTL1 Q9Y468 5/20 0.36
CYP3A4 P08684 3/20 0.36
TDP1 Q9NUW8 3/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
HPGD P15428 5/20 0.35
HSD17B10 Q99714 5/20 0.35
TSHR P16473 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12433950 0.93 GPR84 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17264006 0.91 CYP1A2 (0.36) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12433936 0.90 ALDH1A1 (0.43) CYP1A2MAOAALDH1A1L3MBTL1CYP3A4
SCHEMBL18174848 0.89 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL2208703 0.88 ALDH1A1 (0.42) CYP1A2MAOAALDH1A1L3MBTL1CYP3A4
SCHEMBL12433951 0.88 CYP11B1 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12700373 0.87 CDK4 (0.32) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17264016 0.86 ERBB2 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18079873 0.86 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18174845 0.86 CYP1A2 (0.39) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170029362-A1 LUMINESCENT COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY 2017-02-02 US disclosed
US-20170029362-A1 LUMINESCENT COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY 2017-02-02 US disclosed
US-7981523-B2 Aromatic amine derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2011-07-19 US disclosed
US-7981523-B2 Aromatic amine derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2011-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170029362-A1 LUMINESCENT COMPOUNDS AHR, CCNL2, ARNT CYP1A2 65/4885ERBB2 2322/4885FYN 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.